Variant report
Variant | nsv546569 |
---|---|
Chromosome Location | chr1:73634013-73647909 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12128855 | chr1:73634013-73634014 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs186145601 | chr1:73634053-73634054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112496605 | chr1:73634092-73634093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566044669 | chr1:73634110-73634111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528585295 | chr1:73634111-73634112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541155956 | chr1:73634113-73634114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6684331 | chr1:73634128-73634129 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs529665043 | chr1:73634152-73634153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146825675 | chr1:73634223-73634224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72028568 | chr1:73634224-73634225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs34859883 | chr1:73634233-73634234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146389432 | chr1:73634244-73634245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191868948 | chr1:73634412-73634413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs139432000 | chr1:73634458-73634459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570382222 | chr1:73634476-73634477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564557976 | chr1:73634502-73634503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547738424 | chr1:73634514-73634515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533603747 | chr1:73634605-73634606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6699861 | chr1:73634621-73634622 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs183953068 | chr1:73634670-73634671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541892220 | chr1:73634714-73634715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539331193 | chr1:73634716-73634717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12136496 | chr1:73634781-73634782 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs575331980 | chr1:73634782-73634783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544192691 | chr1:73634830-73634831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112544657 | chr1:73634858-73634859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532794997 | chr1:73634876-73634877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs199636716 | chr1:73634877-73634878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147438130 | chr1:73634878-73634879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71955357 | chr1:73634879-73634880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34092186 | chr1:73634881-73634882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200658510 | chr1:73634882-73634883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546128089 | chr1:73634926-73634927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572697155 | chr1:73634984-73634985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs559889847 | chr1:73635020-73635021 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529512484 | chr1:73635049-73635050 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373617422 | chr1:73635065-73635066 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538838919 | chr1:73635079-73635080 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs188902745 | chr1:73635113-73635114 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548643661 | chr1:73635119-73635120 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12122520 | chr1:73635177-73635178 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs10789357 | chr1:73635188-73635189 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs150035646 | chr1:73635254-73635255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570457622 | chr1:73635261-73635262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190453556 | chr1:73635277-73635278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546509834 | chr1:73635281-73635282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7538384 | chr1:73635284-73635285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566635801 | chr1:73635298-73635299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12137388 | chr1:73635313-73635314 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs555516830 | chr1:73635322-73635323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
abnormal development | 18461090 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:73628400-73641800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr1:73635000-73635200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr1:73635200-73636600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr1:73635400-73636000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr1:73636000-73636200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr1:73636200-73642200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr1:73636600-73641600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr1:73641600-73643000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr1:73641800-73642000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr1:73641800-73642800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr1:73642000-73642400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr1:73642200-73642400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr1:73642200-73643000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr1:73642400-73642600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr1:73642400-73642800 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
16 | chr1:73642400-73642800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr1:73642400-73643000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr1:73642600-73651000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr1:73642800-73653600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |